Amgen: Strong growth company with a challenging future

Since it was founded in 1980, Amgen has established itself as a leading global biotechnology company and built increasingly strong human therapeutics brands as well as state of the art manufacturing facilities. This case study analyses the company's recent financial performance, evaluates the strategies that have helped it become a global leader, and explores what the future may hold.

Scope

Investigation of Amgen’s success and a detailed analysis of its rise to be one of the most innovative biotechnology companies in the world.

Parallel comparisons in terms of R&D, stock market and financial performance to identify its strengths and weaknesses among its peers.

Analysis of the challenges that Amgen faces both internally and externally.

The case study also focuses on the R&D and acquisition strategy of the company.

Reasons to buy

What are the key challenges the company now faces?

Companies mentioned

None

Table of Contents